Skip to Main Content
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

Lobbying Update: $1,250,000 of GOLDMAN SACHS GROUP INC lobbying was just disclosed

None

$1,250,000 of GOLDMAN SACHS GROUP INC lobbying was just disclosed, from Q1 of 2026, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Issues related to US economic competitiveness, housing and global economic issues. P.L. 119-21 and other issues related to tax policy. Issues related to US trade policy. Review of P.L. 85-511 Bank Holding Company Act of 1956 and issues related to global banking policy. Implementation of P.L. 111-203 Dodd-Frank Wall Street Reform and Consumer Protection Act, securitization, market structure, issues related to capital and resolution, issues related to digital assets legislation, issues related to corporate governance, and other issues related to the financial services industry."

You can find more data on corporate lobbying on Quiver Quantitative.

GS Congressional Stock Trading

Members of Congress have traded $GS stock 13 times in the past 6 months. Of those trades, 2 have been purchases and 11 have been sales.

Here’s a breakdown of recent trading of $GS stock by members of Congress over the last 6 months:

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

GS Insider Trading Activity

GS insiders have traded $GS stock on the open market 133 times in the past 6 months. Of those trades, 0 have been purchases and 133 have been sales.

Here’s a breakdown of recent trading of $GS stock by insiders over the last 6 months:

  • DAVID A VINIAR has made 0 purchases and 37 sales selling 68,186 shares for an estimated $65,820,535.
  • JOHN F.W. ROGERS (Executive Vice President) has made 0 purchases and 29 sales selling 15,855 shares for an estimated $15,210,753.
  • DENIS P. COLEMAN (Chief Financial Officer) has made 0 purchases and 12 sales selling 11,623 shares for an estimated $10,943,891.
  • KATHRYN H. RUEMMLER (Chief Legal Officer, GC) has made 0 purchases and 11 sales selling 9,589 shares for an estimated $8,893,930.
  • SHEARA J FREDMAN (Chief Accounting Officer) has made 0 purchases and 18 sales selling 4,863 shares for an estimated $4,492,188.
  • CAREY HALIO (Global Treasurer) has made 0 purchases and 19 sales selling 4,603 shares for an estimated $4,256,247.
  • ALEX S GOLTEN (CHIEF RISK OFFICER) has made 0 purchases and 5 sales selling 2,292 shares for an estimated $2,143,044.
  • DAVID M SOLOMON (Chairman of the Board and CEO) has made 0 purchases and 2 sales selling 272 shares for an estimated $255,387.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

GS Hedge Fund Activity

We have seen 1,337 institutional investors add shares of GS stock to their portfolio, and 1,159 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

GS Analyst Ratings

Wall Street analysts have issued reports on $GS in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • Barclays issued a "Overweight" rating on 01/05/2026

To track analyst ratings and price targets for GS, check out Quiver Quantitative's $GS forecast page.

GS Price Targets

Multiple analysts have issued price targets for $GS recently. We have seen 10 analysts offer price targets for $GS in the last 6 months, with a median target of $1000.0.

Here are some recent targets:

  • Ebrahim Poonawala from B of A Securities set a target price of $1050.0 on 04/14/2026
  • Mike Mayo from Wells Fargo set a target price of $1000.0 on 04/14/2026
  • Erika Najarian from UBS set a target price of $930.0 on 04/13/2026
  • Daniel Fannon from Jefferies set a target price of $1049.0 on 04/06/2026
  • Glenn Schorr from Evercore ISI Group set a target price of $950.0 on 04/06/2026
  • Kian Abouhossein from JP Morgan set a target price of $826.0 on 03/10/2026
  • Gerard Cassidy from RBC Capital set a target price of $1030.0 on 01/20/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles